NeoGenomics, Inc (NASDAQ:NEO) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET
Company Participants
Kendra Sweeney - Vice President, Investor Relations
Chris Smith - Chief Executive Officer
Jeff Sherman - Chief Financial Officer
Vishal Sikri - President, Advanced Diagnostics
Warren Stone - President, Clinical Services
Melody Harris - President, Enterprise Operations
Conference Call Participants
Dan Brennan - TD Cowen
Alex Nowak - Craig-Hallum Capital Group
David Delahunt - Goldman Sachs
Mark Massaro - BTIG
Tejas Savant - Morgan Stanley
Derik De Bruin - Bank of America
Mike Matson - Needham & Company
Mason Carrico - Stephens
Andrew Cooper - Raymond James
Operator
Welcome to the NeoGenomics Second Quarter 2023 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. Please note this call is being recorded, and an audio replay will be available on the company’s website. Kendra Sweeney, Vice President of Investor Relations, you may begin your conference.
Kendra Sweeney
Thank you, Jenny. Good morning everyone and welcome to the NeoGenomics second quarter financial results call. With me today to discuss the results are Chris Smith, Chief Executive Officer; and Jeff Sherman, Chief Financial Officer. Additional members of the management team are available for Q&A, including Vishal Sikri, President of Advanced Diagnostics; Warren Stone, President of Clinical Services; and Melody Harris, President of Enterprise Operations. This call is being simultaneously webcast. We will be referring to a slide presentation that has been posted to the Investors tab on our website at ir.neogenomics.com.
Starting on Slide 2. During this call, we will make forward-looking statements regarding our anticipated future performance, such as our operational and financial outlooks and suggestions, our assumptions for that outlook, opportunities, and strategies for our products, and related effects on our financial and operating results. We caution you that such statements reflect our best judgment based on factors currently known to us and that actual events or results could differ materially.
Please refer to our most recent Fort 10-K and 10-Q and the 8-K we filed with the SEC to identify important risks and other factors that may cause our actual results to differ materially from those contained in or suggested by the forward-looking statements. The forward-looking statements made during this call speak only as of the original date of the call, and we undertake no obligation to update or revise any of these statements.
During this conference call, in order to provide greater transparency regarding our operating performance, we will refer to certain non-GAAP financial measures that involve adjustments to GAAP results. The non-GAAP financial measures presented should not be considered an alternative to the financial measures required by GAAP, should not be considered measures of liquidity, and are unlikely to be comparable to non-GAAP financial measures provided by other companies. Any non-GAAP financial measures referenced on this call are reconciled to the most directly comparable GAAP financial measure in a table available in the press release we issued this morning.